This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nipd Genetics Public Company Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Inventor Spotlight: Skevi Kyriakou - Pioneering Genetic Risk Assessment
Introduction: Skevi Kyriakou, a talented inventor based in Larnaca, Cyprus, has made significant strides in the field of genetic testing. With her innovative approach, she has developed a patented method for assessing the risk of genetic conditions, particularly useful in prenatal testing.
Latest Patents: Skevi’s single patent, titled "Target-enriched multiplexed parallel analysis for assessment of risk for genetic conditions," outlines a groundbreaking method that utilizes Target Capture Sequences (TACS) to enhance the detection of target sequences of interest. This advanced technique employs massive parallel sequencing combined with statistical analysis, allowing for a more accurate determination of carrier status for inheritable genetic abnormalities. The technology not only evaluates fetal risk for genetic conditions but also provides essential kits for carrying out these innovative methods.
Career Highlights: Skevi Kyriakou is currently associated with Nipd Genetics Public Company Ltd., where she applies her expertise in genetics to advance the capabilities of genetic testing. Her work has been instrumental in improving methodologies necessary for assessing genetic risks, which is crucial for informed medical decisions during pregnancy.
Collaborations: Throughout her career, Skevi has collaborated with professionals such as George Koumbaris and Marios Ioannides. Together, they contribute to the innovation landscape at Nipd Genetics, enhancing the company’s position as a leader in genetic diagnostics.
Conclusion: Skevi Kyriakou's contributions to the field of genetic risk assessment exemplify how innovative inventions can transform healthcare practices. Her patent stands as a testament to her dedication and ingenuity in improving prenatal diagnostics, offering hope and clarity to expecting families. With her ongoing work at Nipd Genetics and her collaborations with fellow professionals, Skevi continues to push the boundaries of what is possible in genetic research and testing.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile